TrialScientific reports2023

Maintenance intravenous iron in hemodialysis patients to minimize erythropoietin doses: a double-blinded, randomized controlled trial (the MAINTAIN IRON trial).

Suthiya Anumas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.